158 related articles for article (PubMed ID: 21259063)
1. Expression of matrix metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: clinical and morphological parallels.
Uloza V; Liutkevičius V; Pangonytė D; Saferis V; Lesauskaitė V
Eur Arch Otorhinolaryngol; 2011 Jun; 268(6):871-8. PubMed ID: 21259063
[TBL] [Abstract][Full Text] [Related]
2. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
[TBL] [Abstract][Full Text] [Related]
3. Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
Pakkanen PP; Aaltonen LM; Sorsa TA; Tervahartiala TI; Hagström JK; Ilmarinen TT
Head Neck; 2019 Feb; 41(2):309-314. PubMed ID: 30549356
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Expression of Matrix Metalloproteinases (MMP-2 and MMP-9) in Glottic Squamous Cell Carcinoma and Benign Vocal Fold Lesions.
Uloza V; Liutkevicius V; Pangonyte D; Lesauskaite V
Clin Exp Otorhinolaryngol; 2015 Mar; 8(1):57-64. PubMed ID: 25729497
[TBL] [Abstract][Full Text] [Related]
5. Low expression of nuclear Toll-like receptor 4 in laryngeal papillomas transforming into squamous cell carcinoma.
Ilmarinen T; Hagström J; Haglund C; Auvinen E; Leivo I; Pitkäranta A; Aaltonen LM
Otolaryngol Head Neck Surg; 2014 Nov; 151(5):785-90. PubMed ID: 25205638
[TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinases (MMP-2,-3,-9) Gene Polymorphisms in Cases of Benign Vocal Fold Lesions and Laryngeal Carcinoma.
Liutkevicius V; Lesauskaite V; Liutkeviciene R; Vaiciulis P; Uloza V
In Vivo; 2020; 34(1):267-274. PubMed ID: 31882488
[TBL] [Abstract][Full Text] [Related]
7. Expression of type IV collagen, metalloproteinase-2, metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in laryngeal squamous cell carcinomas.
Cao XL; Xu RJ; Zheng YY; Liu J; Teng YS; Li Y; Zhu J
Asian Pac J Cancer Prev; 2011; 12(12):3245-9. PubMed ID: 22471461
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
Liu WW; Zeng ZY; Wu QL; Hou JH; Chen YY
Otolaryngol Head Neck Surg; 2005 Mar; 132(3):395-400. PubMed ID: 15746850
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions.
Peschos D; Damala C; Stefanou D; Tsanou E; Assimakopoulos D; Vougiouklakis T; Charalabopoulos K; Agnantis NJ
Histol Histopathol; 2006 Jun; 21(6):603-8. PubMed ID: 16528670
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma.
Liu Y; Li Y; Liu Z; Zhang L; Anniko M; Duan M
Acta Otolaryngol; 2011 Jul; 131(7):769-73. PubMed ID: 21466263
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases (MMP-2 and MMP-9) in vocal fold polyps.
Lesauskaite V; Uloza V; Liutkevicius V; Pangonyte D
Medicina (Kaunas); 2008; 44(4):322-7. PubMed ID: 18469510
[TBL] [Abstract][Full Text] [Related]
12. Differentiated expression of membrane type metalloproteinases (MMP-14, MMP-15) and pro-MMP2 in laryngeal squamous cell carcinoma. A novel mechanism.
Bodnar M; Szylberg L; Kazmierczak W; Marszalek A
J Oral Pathol Med; 2013 Mar; 42(3):267-74. PubMed ID: 22998427
[TBL] [Abstract][Full Text] [Related]
13. Determination of matrix metalloproteinase 9 (MMP-9) protein expression in laryngeal squamous cell carcinomas based on digital image analysis.
Papadas TA; Naxakis SS; Mastronikolis NS; Stathas T; Karabekos NCh; Tsiambas E
J BUON; 2013; 18(4):977-81. PubMed ID: 24344026
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9, myofibroblasts and Ki-67 in actinic cheilitis and lip squamous cell carcinoma.
Bianco BC; Scotti FM; Vieira DS; Biz MT; Castro RG; Modolo F
Int J Exp Pathol; 2015 Oct; 96(5):311-8. PubMed ID: 26515234
[TBL] [Abstract][Full Text] [Related]
15. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression.
Go C; Schwartz MR; Donovan DT
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):298-302. PubMed ID: 12731623
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of matrix metalloproteinase-2 in laryngeal squamous cell carcinoma].
Wang X; Shan Y; Wang J; Luo S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Dec; 20(24):1109-10. PubMed ID: 17357514
[TBL] [Abstract][Full Text] [Related]
17. Stage-specific expression analysis ofMMP-2 & MMP-9 in laryngeal carcinoma.
Bakshi J; Goyal AK; Singh V; Sannigrahi M; Khullar M
J Cancer Res Ther; 2020; 16(3):517-520. PubMed ID: 32719260
[TBL] [Abstract][Full Text] [Related]
18. [Expression and role of survivin in laryngeal squamous cell carcinoma and laryngeal papilloma in adults].
Xie H; Zhang B; Yin J; Song F
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(9):413-6. PubMed ID: 17634026
[TBL] [Abstract][Full Text] [Related]
19. Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas.
Krecicki T; Fraczek M; Jelen M; Podhorska M; Szkudlarek T; Zatonski T
Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):494-7. PubMed ID: 12739032
[TBL] [Abstract][Full Text] [Related]
20. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
